CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- 4 Planned sale Director sold 2,155 shares at $37.00 ($79,735)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale General Counsel sold 1,500 shares at an average $30.99 ($46,481)
- 4 Planned sale General Counsel sold 1,252 shares at $31.58 ($39,542)
- 4 Planned sale Kelsey Stephen Michael sold 2,123 shares at $31.58 ($67,051)
- 4 Planned sale Chief Operating Officer sold 2,914 shares at $31.58 ($92,033)
- 4 Planned sale GOLDSMITH MARK A sold 5,788 shares at $31.58 ($182,804)
- 4 Planned sale Chief Financial Officer sold 1,261 shares at $31.58 ($39,826)
- 4 Planned sale Chief Operating Officer sold 23,671 shares at an average $34.04 ($805,652)
- 4 Grant or award Chief Operating Officer acquired 41,000 shares (grant or award)
- 4 Grant or award GOLDSMITH MARK A acquired 90,000 shares (grant or award)
- 4 Grant or award General Counsel acquired 21,000 shares (grant or award)
- 4 Grant or award Kelsey Stephen Michael acquired 51,400 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 26,400 shares (grant or award)
- 4 Grant or award Wang Xiaolin acquired 24,200 shares (grant or award)
- 4 Planned sale General Counsel sold 1,500 shares at $27.00 ($40,500)
- 4 Planned sale Kelsey Stephen Michael sold 3,337 shares at $29.01 ($96,809)
- 4 Planned sale Kelsey Stephen Michael sold 13,330 shares at $29.10 ($387,884)
- 4 Planned sale Kelsey Stephen Michael sold 33,334 shares at $29.01 ($966,996)
- 4 Planned sale Chief Financial Officer sold 1,775 shares at $25.90 ($45,976)
Page 10 of 21 · 414 filings